Ecolab, a technology company that makes devices to monitor the heart, lung, skin, and other body parts, is developing an app that allows people to easily track the progress of their blood pressure and other health issues using sensors on their smartphones.

It is using the technology to help doctors monitor their patients’ progress, with the app showing an indicator when a patient has had a blood pressure drop and can expect to have more blood pressure in the future.

It also alerts them if a patient’s skin condition is worsening or they are in danger of contracting an infection.

The app will be launched on a range of smart medical devices, including the Fitbit Charge HR and the Philips Hue light bulb. 

“Smart medical devices will become a key part of the modern healthcare delivery system,” said Dr Jonathan Wood, CEO of Ecolabs. 

Ecolab has already acquired a large number of medical devices and has set up a joint venture with a leading manufacturer of medical device sensors. 

It has a research and development partnership with the manufacturer, Mediagenix.

The company said the device would also be used to track the health status of people who are undergoing a physical test and have symptoms that are associated with high blood pressure. 

The app is currently being developed with the help of doctors and other healthcare professionals. 

Its main challenge will be to get enough data from patients in order to identify and diagnose serious illnesses. 

Medical devices are used by around 20 million people every day, but experts warn they have not always been as accurate as doctors say. 

Data from health devices can be difficult to interpret and some may be unreliable, according to a report by the European Commission. 

A report from the UK government in December revealed the use of data from health-related devices by almost half a million people was not accurate. 

However, the report said health-care organisations could use the data to make better decisions about their patients, and to make sure people with a high risk of dying or developing serious illnesses were identified and treated early. 

Health officials say that is a big challenge. 

Dr Wood said the technology will allow doctors to take more accurate data, which will help them make better health-based recommendations to patients.

“The device will be able to provide accurate and up-to-date information that can inform the medical team, particularly the doctors, of a patient who is on their way to dying or at risk of death,” he said. 

In the US, Ecola was bought by Google in 2014 for $300 million and is currently one of the largest medical device makers in the world. 

This article first appeared in RTE magazine.